Johnson R, Lancki D W, Fitch F W
Department of Pathology, University of Chicago, IL 60637.
J Immunol. 1993 Sep 15;151(6):2986-99.
The murine T cell surface molecules Ly-6C and Thy-1 are genetically and structurally distinct, yet they share two interesting properties: both are attached to the plasma membrane through a glycophosphatidylinositol linkage, and some mAb reactive with these molecules can activate T cells. Although mAb for Ly-6C and Thy-1 appear to mimic the function of physiologic ligands, direct evidence for the existence of these putative ligands has not been presented. In this report, we describe CTL clones that use Ly-6C and Thy-1 as accessory molecules for activation of cytolysis and the production of IFN-gamma based on inhibition of these functions with mAb. These studies were facilitated by the derivation of a nonactivating hamster IgM mAb specific for Ly-6C. CTL clones that use Ly-6C and Thy-1 as accessory molecules include a subpopulation of the previously described CD8+ alloreactive CTL that are not inhibited by mAb reactive with CD8, a CD8+ TCR-alpha/beta+ T cell clone specific for HSV glycoprotein D, and a CD4-CD8- TCR-gamma/delta+ T cell clone specific for HSV glycoprotein I. The role of Ly-6C and Thy-1 in target cell recognition is to some degree tissue-specific with respect to the APC/target cell. A mAb specific for Ly-6C appears to inhibit activation by prevention of adhesion between the effector cells and the target cells. This is the most direct evidence to date of a functional ligand for Ly-6C.
小鼠T细胞表面分子Ly-6C和Thy-1在基因和结构上是不同的,但它们具有两个有趣的共同特性:二者均通过糖基磷脂酰肌醇连接附着于质膜,并且一些与这些分子反应的单克隆抗体(mAb)可激活T细胞。尽管针对Ly-6C和Thy-1的单克隆抗体似乎模拟了生理配体的功能,但尚未提供这些假定配体存在的直接证据。在本报告中,我们描述了一些细胞毒性T淋巴细胞(CTL)克隆,这些克隆基于用单克隆抗体抑制这些功能,将Ly-6C和Thy-1用作激活细胞溶解和产生γ干扰素的辅助分子。针对Ly-6C的非激活仓鼠IgM单克隆抗体的衍生促进了这些研究。将Ly-6C和Thy-1用作辅助分子的CTL克隆包括先前描述的CD8+同种异体反应性CTL的一个亚群,这些CTL不受与CD8反应的单克隆抗体的抑制,一个对单纯疱疹病毒糖蛋白D特异的CD8+TCR-α/β+T细胞克隆,以及一个对单纯疱疹病毒糖蛋白I特异的CD4-CD8-TCR-γ/δ+T细胞克隆。Ly-6C和Thy-1在靶细胞识别中的作用在某种程度上相对于抗原呈递细胞/靶细胞是组织特异性的。一种针对Ly-6C的单克隆抗体似乎通过阻止效应细胞与靶细胞之间的粘附来抑制激活。这是迄今为止关于Ly-6C功能配体的最直接证据。